Peptide Knowledge Base · Cosmetic

Acetyl-Hexapeptide-8 (Argireline): what it is, what the evidence says, and its real status

The topical 'Botox-in-a-jar' peptide your serum may already contain. Cosmetic-grade evidence, low risk, and legal as a topical, a clean top-of-funnel education entry.

Can you actually get it?

Plain-English verdict: No availability record.

Regulatory status: No regulatory record.

How does Acetyl-Hexapeptide-8 (Argireline) work?

A peptide proposed to modestly reduce muscle-contraction signaling at the skin surface, softening the appearance of expression lines.

What it does — and what it does not do

What it does: Used topically to soften the look of fine expression lines; low-risk and widely formulated.

What it does not do: It is not injectable Botox and not a wrinkle cure; topical effect sizes are modest.

How honest is the evidence?

Evidence grade C — Mixed / early human evidence.

cosmetic-grade topical evidence; modest effect sizes

A grade measures how much human evidence exists, not whether a molecule is good, safe, or worth your interest. Read our grading methodology for what each grade means.

What we still don't know: Topical penetration and real-world effect size vary by formulation; it is not a substitute for procedures.

WADA status: Not prohibited.

How it is taken

Per cosmetic formulation; topical only.

Who should not take it

Topical: generally well tolerated; patch-test for sensitivity.

Sources

Acetyl-hexapeptide-8 (Argireline) cosmetic-peptide literature

Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker for status.

Join the founding list →

Embed this card on your site · free, CC BY 4.0, no key.

Last reviewed Jun 18, 2026 · Peptós.LIFE · Not medical advice.